BioScience Health Innovations (BHIC) Long-Term Debt Issuances (2019 - 2025)
Historic Long-Term Debt Issuances for BioScience Health Innovations (BHIC) over the last 6 years, with Q3 2025 value amounting to $1.0 million.
- BioScience Health Innovations' Long-Term Debt Issuances rose 27563.92% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 18352.48%. This contributed to the annual value of $962848.0 for FY2024, which is 5682.25% up from last year.
- Latest data reveals that BioScience Health Innovations reported Long-Term Debt Issuances of $1.0 million as of Q3 2025, which was up 27563.92% from $802119.0 recorded in Q2 2025.
- BioScience Health Innovations' Long-Term Debt Issuances' 5-year high stood at $1.0 million during Q3 2025, with a 5-year trough of $1200.0 in Q2 2021.
- In the last 4 years, BioScience Health Innovations' Long-Term Debt Issuances had a median value of $232837.0 in 2024 and averaged $308151.3.
- As far as peak fluctuations go, BioScience Health Innovations' Long-Term Debt Issuances skyrocketed by 80000.0% in 2021, and later skyrocketed by 517.99% in 2024.
- Quarter analysis of 4 years shows BioScience Health Innovations' Long-Term Debt Issuances stood at $5850.0 in 2021, then soared by 4289.74% to $256800.0 in 2023, then rose by 5.18% to $270102.0 in 2024, then surged by 281.51% to $1.0 million in 2025.
- Its Long-Term Debt Issuances was $1.0 million in Q3 2025, compared to $802119.0 in Q2 2025 and $589516.0 in Q1 2025.